4-in-1 Test Approved for Coronavirus, RSV and Influenza Viruses

California based Cepheid announced on September 29, 2020, it has received Emergency Use Authorization from the U.S. FDA for Xpert® Xpress SARS-CoV-2/Flu/RSV, a 4 in 1 rapid molecular diagnostic test for the qualitative detection of the viruses causing COVID-19, Flu A, Flu B, and RSV infections from a single patient sample, with results delivered in approximately 36 minutes.

Dr. David Persing, Chief Medical and Technology Officer at Cepheid stated in a press release: "The ability to run a single, highly sensitive test that detects all 4 viruses in a syndromic panel provides actionable results and helps to alleviate pressure on our healthcare system."